SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-201791
Filing Date
2023-08-02
Accepted
2023-08-02 17:05:32
Documents
13
Period of Report
2023-08-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d457542d8k.htm   iXBRL 8-K 29335
2 EX-10.1 d457542dex101.htm EX-10.1 43468
  Complete submission text file 0001193125-23-201791.txt   209668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA slrn-20230802.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrn-20230802_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrn-20230802_pre.xml EX-101.PRE 11252
7 EXTRACTED XBRL INSTANCE DOCUMENT d457542d8k_htm.xml XML 3347
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 231136805
SIC: 2834 Pharmaceutical Preparations